GGrantIndex
← Leaderboards

David Veesler

University Of Washington

$16,345,259
Attributed
$19,210,369
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $49.7M · FY201625
$50M$37.5M$25M$12.5M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$69,351,051 · 8

By mechanism

U19$47,946,907 · 2
P01$9,947,294 · 2
R01$6,014,350 · 3
DP1$5,442,500 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Design

Research focus

DesignProteinsAntibodiesVirusInfectionGlycoproteinsMolecularViralBindingReceptorLeadPublic HealthStructurePathogenPandemic DiseaseResolutionDisease OutbreaksCellsProtein EngineeringReceptor BindingCoronavirusVirus DiseasesVaccinesAntigens

Grant awards (23)

De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$671,529
R01 · FY2025 · AI
Machine learning-enabled design of prototype pathogen vaccines and antibodies$41,075,241
U19 · FY2024 · AI
Project 2: Viral entry, antibodies, and structural biology$6,871,666
U19 · FY2024 · AI · contact PI
Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics$1,088,500
DP1 · FY2024 · AI · contact PI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$692,102
R01 · FY2024 · AI
Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics$1,088,500
DP1 · FY2023 · AI · contact PI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$703,773
R01 · FY2023 · AI
Structure-based design of broadly protective coronavirus vaccines$9,065,441
P01 · FY2022 · AI
Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics$1,088,500
DP1 · FY2022 · AI · contact PI
Project 1: Definition of the structural principles underlying broadly protective humoral immunity to coronaviruses$881,853
P01 · FY2022 · AI · contact PI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$713,861
R01 · FY2022 · AI
Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics$1,088,500
DP1 · FY2021 · AI · contact PI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$723,634
R01 · FY2021 · AI
Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics$1,088,500
DP1 · FY2020 · AI · contact PI
Structural Studies of Coronavirus Fusion Proteins$294,397
R01 · FY2020 · GM · contact PI
Structural mechanisms for gating of bacterial cyclic nucleotide-gated ion channels$396,383
R01 · FY2019 · GM
Structural Studies of Coronavirus Fusion Proteins$293,325
R01 · FY2019 · GM · contact PI
Structural Studies of Coronavirus Fusion Proteins$89,600
R01 · FY2019 · GM · contact PI
Structural mechanisms for gating of bacterial cyclic nucleotide-gated ion channels$396,383
R01 · FY2018 · GM
Structural Studies of Coronavirus Fusion Proteins$292,683
R01 · FY2018 · GM · contact PI
Structural Studies of Coronavirus Fusion Proteins$167,402
R01 · FY2018 · GM · contact PI
Structural Studies of Coronavirus Fusion Proteins$289,950
R01 · FY2017 · GM · contact PI
Structural Studies of Coronavirus Fusion Proteins$289,328
R01 · FY2016 · GM · contact PI